Tumor necrosis factor (TNF) is a monokine with in vitro cytotoxicity for some but not all tumor cells. The basis for sensitivity and resistance to the antitumor effects of this agent remains unclear. The present studies have monitored the effects ofTNF on 14 epithelial tumor cell lines. Eleven of these cell lines were resistant to the growth inhibitory effects of TNF (50% inhibitory concentration > 1,000 U/ml). 12 of the 14 tumor cell lines has detectable levels of high affinity cell surface TNF binding sites, thus suggesting that resistance was not often due to the absence of cell surface TNF receptors. Northern blot analysis demonstrated that three of the eleven resistant cell lines expressed detectable levels of TNF mRNA. Furthermore, both sensitive and resistant epithelial tumor cells had the capacity to express TNF transcripts in the presence of the protein synthesis inhibitor, cycloheximide. Finally, the presence of TNF expression at the RNA level is shown to be associated with the production of a TNF-like protein in the resistant Ov-D ovarian carcinoma cells. These findings suggest that certain human epithelial tumor cell lines inherently resistant to TNF also express this cytokine.
Introduction
Tumor necrosis factor (TNF)' is a polypeptide cytokine with a variety of in vitro and in vivo effects. TNF was first identified in the serum of mice challenged with endotoxin after BCG innoculation (1) . Infusions of serum containing TNF into untreated mice induced hemorrhagic necrosis of transplanted subcutaneous tumors. The purified TNF protein was also found to be cytotoxic or cytostatic for a number of human and murine tumor cell lines in vitro and in vivo (1) .
TNF has been shown to mediate certain effects in normal cells. TNF functions as a growth factor for human diploid fibroblasts in vitro and activates a variety of immune effector cells (2) (3) (4) (5) . Polymorphonuclear neutrophils are stimulated by TNF to increase respiratory activity, phagocytosis, superoxide formation, and antibody-dependent cellular cytotoxicity (3) (4) (5) . Eosinophil cytotoxicity for Schistosoma mansoni larvae is also enhanced by TNF (6) . Resting macrophages produce interleukin 1 and prostaglandin E2 after TNF exposure, and TNF has been shown to be an important effector molecule for macrophage cytotoxicity after activation (7, 8) . TNF also promotes bone resorption, stimulates the production of granulocyte-macrophage colony-stimulating factor, inhibits lipogenic gene expression in adipocytes, and stimulates the production of collagenase and prostaglandin E2 by synovial cells (9) (10) (11) (12) . Endothelial cells exposed to TNF have enhanced procoagulant activity and suppression ofthe protein C pathway (13) . Passive immunization against TNF can protect mice from the lethal effects of endotoxin, suggesting that TNF is an important mediator in the physiology of endotoxic shock (14) . Administration of recombinant TNF to rats elicits many of the pathophysiologic changes associated with endotoxemia including acidosis and respiratory arrest (15) .
The antitumor effects of TNF are not well understood. Direct cytotoxicity is apparently mediated by specific binding to high affinity cell surface receptors. However, the presence of cell surface receptors is not sufficient for cytotoxicity since normal. cells and TNF-resistant tumor cells also have high specificity cell surface receptors (16, 17) . The cytotoxic effects of TNF appear to be cell cycle specific. TNF causes accumulation of cells in G2 phase and cytolysis in the late stages of mitosis (18) . Inhibitors ofprotein synthesis and RNA synthesis result in increased TNF cytotoxicity, and L929 cells that are not rapidly proliferating are more sensitive to the cytotoxic effects of this agent (1 9, 20) . Combinations of TNF and either alpha or gamma interferon show synergistic cytotoxicity for certain human tumor cell lines (21) . Interferons increase the number of cell surface TNF receptors, but this observation may not be related to the cytotoxic synergy ( 19, 21 Toxicity assays. Sensitivity to TNF was determined using a 96-well plate assay. 10,000 tumor cells were plated into each well and incubated for 5-7 d with increasing concentrations of TNF. The cells were then fixed with 2.5% glutaraldehyde, washed and stained with 0.05% methylene blue. After 5 min, the plates were washed and the dye released with 0.33 N HCI. The absorbance ofeach well was determined with an automated plate reader (Bio-Rad Laboratories, Richmond CA). The effect of TNF was determined by comparing absorbance of TNF-treated cells with that obtained for untreated control cells.
Radiolabeling of TNF. Human recombinant TNF (PAC-4D) was provided by Asahi Chemical Industry America, Inc., New York, NY (24) . The TNF protein was labeled with 1251 by the Iodogen method and purified by gel filtration (16) . The labeled protein was homogenous by SDS-PAGE (Fig. 1 A) Measurement of TNF levels. Determinations of TNF protein were made using cell culture supernatants and cell lysates. Immunologic activity was determined by analysis in the previously described ELISA, which used two monoclonal antibodies reactive with distinct epitopes on the TNF molecule (25) . Biological activity was determined in a L cell cytotoxicity assay standardized with recombinant TNF. 1 U in the ELISA was defined as the amount of TNF required for 50% cytotoxicity in the L929 cells (22) .
Northern blot analysis. Total cellular RNA was collected from all human tumor cell lines utilizing the guanidine thiocyanate/cesium chloride method as previously described (26) . The purified RNA (20 ,ug) was analyzed by electrophoresis through 1% agarose-formaldehyde gels followed by Northern blot transfer to nitrocellulose paper. The TNF probe (generously provided by Dr. P. Ralph, Cetus Corp., Emeryville, CA) was nick translated to a specific activity of 5 x 1o8 cpm/gg DNA (27) . The nitrocellulose filters were prehybridized at 42°C for 16-24 h in buffer consisting of 50% formamide, Sx standard saline citrate (SSC) (0.15 M NaCl; 0.015 M Na3citrate = I X SSC), 0.1% SDS, 5x Denhart's solution, and 200 ,g/ml salmon sperm DNA. The filters were then incubated for an additional 24 h in the same buffer with 2 X 106 cpm/ml of labeled probe. After hybridization the blots were washed twice in 0.1% SDS, 2x SSC for 60 min at room temperature, and then washed two more times with 0.1% SDS, 0.1 x SSC at 55°C. The blots were then dried and exposed to x-ray film for 10 lyzed by SDS-PAGE; using 7.5% polyacrylamide slab gels with Tris glycine buffer (28) . Gels were treated with Amplify TM (Amersham Corp., Arlington Heights, IL) for fluorography before drying. Autoradiography was performed at -70°C using Kodak x-ray film.
Results
14 human epithelial tumor cell lines were tested for sensitivity to TNF growth inhibition. The results are listed in Table I .
Resistance to TNF was defined as an IC50 of > 1,000 U/ml TNF in the 7-d growth inhibition assay. The three sensitive breast carcinoma cell lines (BT-20, MCF-7, and ZR-75-1) had IC50 of < 10 U/ml while all of the other eleven cell lines had <50% growth inhibition at 1,000 U/ml TNF and were considered to be resistant to the cytotoxic effects of TNF. Fig. 1 (22, 23) . Levels of TNF mRNA in the epithelial tumor cell lines were therefore examined using total cellular RNA and Northern blot analysis. None of the three human cell lines sensitive to the cytotoxic effects of TNF had detectable TNF transcripts (Fig. 2) . In contrast, the TNF cDNA probe hybridized to a 1.6-kb transcript in three of the eleven lines resistant to TNF cytotoxicity. Two of four ovarian carcinoma cell lines (Ov-A and Ov-D) and one of four lung carcinoma lines (NCI-69) had detectable amounts of TNF transcripts (Fig. 2) . Resistant L cells, but not the wild type, sensitive L cells, also had detectable TNF mRNA (Fig. 2) . Studies on mouse monocytes have demonstrated that TNF production is regulated at both transcriptional and posttranscriptional levels (28) . We have recently demonstrated that TNF expression in activated human monocytes is superinducible during inhibition of protein synthesis (unpublished data). In view of these findings, all 14 human epithelial cells were examined for the production of TNF transcripts in the presence of cycloheximide (Fig. 3). 1-3 ester-stimulated monocytes. Immunoreactive TNF was not detectable in any of the culture supernatants from the 14 human epithelial tumor cells. Furthermore, cell lysates of each tumor cell line were also examined by ELISA and no detectable TNF was found. Western blot analysis ofboth cell culture supernatants and lysates obtained from each of the 14 human cell lines were also negative for TNF protein.
The absence of detectable TNF in supernatants of epithelial tumor cell lines may have been due to levels below the sensitivity of our assay. We therefore studied cytotoxic activity in cell culture supernatants using the L cell cytotoxicity assay (22) . As recently reported, the resistant L cell culture supernatant was cytotoxic for L cells (22) . In contrast, no cytotoxic activity was present in the supernatant from any of the epithelial tumor cell lines. Even 50-fold concentrates of supernatants from the TNF resistant Ov-D ovarian cell line and the sensitive MCF-7 breast carcinoma line did not contain demonstrable cytotoxic activity for L cells.
The Ov-D and MCF-7 cells were further studied by protein labeling with [3H]-leucine and immunoconcentration using The Ov-D cell lysate also had an immunoprecipitable protein band at 45,000 D. The appearance of these radioactive bands was completely blocked by an excess of cold recombinant TNF. In contrast, these proteins were undetectable in the cell culture supernatant and cell lysate of MCF-7 cells. Since monomeric TNF has an Mr of 17,000, these findings suggest that Ov-D ovarian carcinoma cells express TNF at both the RNA and protein levels. The cell lysate of Ov-D cells also contained a second immunoreactive band at a Mr of 45,000 on SDS-PAGE. A similar immunoreactive 45-kD protein was also identified by other workers during the purification and characterization of LuKII TNF (29) . Discussion TNF is cytotoxic or inhibitory to a variety of human tumor cell lines (19, 21) . Some (23) . Taken together, these studies suggest that production of TNF by epithelial tumor cells resistant to TNF may represent a novel mechanism of resistance.
In the present study, 3 human epithelial tumor cell lines were sensitive to the growth inhibitory effects ofTNF, while 11 were resistant. None of the 11 human epithelial tumor cell lines had been previously exposed to exogenous TNF. In contrast to the TNF-resistant L929 subline, 12 
